Cable Hill Partners’s Avanos Medical AVNS Stock Holding History

Cable Hill Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-121	Closed	-$5K	–	152
2019 Q1	$5K	Sell	121 -26	-18%	-$1.16K	﹤0.01%	594
2018 Q4	$7K	Buy	147 +88	+149%	+$4.61K	﹤0.01%	498
2018 Q3	$4K	Hold	59	–	–	﹤0.01%	601
2018 Q2	$3K	Hold	59	–	–	﹤0.01%	759
2018 Q1	$3K	Sell	59 -100	-63%	-$4.75K	﹤0.01%	754
2017 Q4	$7K	Hold	159	–	–	﹤0.01%	645
2017 Q3	$7K	Hold	159	–	–	﹤0.01%	661
2017 Q2	$6K	Hold	159	–	–	﹤0.01%	506
2017 Q1	$6K	Hold	159	–	–	﹤0.01%	492
2016 Q4	$6K	Sell	159 -23	-13%	-$822	﹤0.01%	503
2016 Q3	$6K	Buy	182 +123	+208%	+$4.31K	﹤0.01%	522
2016 Q2	$2K	Buy	+59	New	+$1.81K	﹤0.01%	620
2015 Q3	–	Sell	-62	Closed	-$3K	–	705
2015 Q2	$3K	Sell	62 -12	-16%	-$539	﹤0.01%	631
2015 Q1	$4K	Hold	74	–	–	﹤0.01%	599
2014 Q4	$3K	Buy	+74	New	+$2.91K	﹤0.01%	603

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cable Hill Partners's AVNS Position: Q2 2019 in Review

Cable Hill Partners sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 121 shares — an estimated $5K sold.

Cable Hill Partners first reported a position in AVNS in Q4 2014 and held it in 15 quarters. The position peaked at $7K in Q4 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Cable Hill Partners reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 121 Avanos Medical shares in Q2 2019, an estimated $5K.
Cable Hill Partners first reported a position in Avanos Medical in Q4 2014 and held it in 15 quarters.
Cable Hill Partners's Avanos Medical position peaked at $7K in Q4 2018.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.